JPMED

Company Overview

Snapshot

Founded in February 1999 by Eitan Harduf and Doron Friedman, JPMED operates with 1–10 employees. The company holds a patent for its drug delivery systems.

Business overview

JPMED develops and commercializes products for treating skin, ear, and mouth ailments. The company's core technology is an oil-in-glycerin emulsion designed to dissolve essential oils without harsh chemicals. Its product portfolio includes Ear Comfort ear drops and Free Rinse mouthwash. JPMED's products are registered for human use in Israel and are undergoing registration in Australia and New Zealand, targeting the pharmaceuticals sector within Health Tech & Life Sciences.

Company Intelligence Q&A

What is JPMED's core technology?

JPMED's core technology is a patent-protected oil-in-glycerin emulsion system designed for dissolving essential oils without the need for alcohol, harsh chemicals, or synthetic solvents. This system forms the basis for its various therapeutic products.

What products has JPMED developed?

JPMED has developed several products, including Ear Comfort (steroid- and antibiotic-free ear drops), Free Rinse mouthwash, Aphta Gel (for canker sores), and Ora Protect (for mucositis). These products utilize the company's proprietary emulsion-based drug delivery system.

In which markets are JPMED's products available or being registered?

JPMED's products are registered for human use in Israel and are currently undergoing registration processes in Australia and New Zealand.

Who are the founders of JPMED?

JPMED was co-founded by Eitan Harduf and Doron Friedman.

When was JPMED founded?

JPMED was founded in February 1999.